Article: GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry.

Article: GSK appoints Zhi Hong as head of ID CEDD.
Pharma Marketletter;  April 9, 2007 ;     306 words ...UK-based drug major GlaxoSmithKline has appointed Zhi Hong as the leader of its Infectious Diseases Center of Excellence for Drug Discovery, effective April 23.

Article: Anacor Pharmaceuticals Raises $25 Million in Series C ...
PR Newswire;  May 11, 2005 ;     700+ words ... ... Calif., May 11 /PRNewswire/ -- Anacor Pharmaceuticals, a biotechnology company ... used to fund the clinical development of Anacor's first two products through Phase II ... and to advance other research programs. Anacor also announced today that Richard J ...

Article: Anacor Signs Worldwide Exclusive License Agreement With ...
PR Newswire;  February 2, 2007 ;     700+ words ...Anacor to Receive $40 Million Upfront, $575 ... ALTO, Calif., Feb. 2 /PRNewswire/ -- Anacor Pharmaceuticals, a privately held pharmaceutical ... population. Under the terms of the agreement, Anacor will receive a $40 million upfront payment ...

Article: Anacor Pharmaceuticals Names Dr. Jacob J. Plattner Head of ...
PR Newswire;  March 1, 2004 ;     700+ words ... ... Calif., March 1 /PRNewswire/ -- Anacor Pharmaceuticals, an early-stage pharmaceutical ... development of technology initially created by Anacor Co-Founders Dr. Lucy Shapiro at Stanford ... Benkovic at Pennsylvania State University. Anacor is using this research base to develop ...

Article: Anacor Achieves Milestone from GSK for Boron-Based ...
PR Newswire;  January 12, 2009 ;     700+ words ... ... Calif., Jan. 12 /PRNewswire/ -- Anacor Pharmaceuticals today announced that it ... collaboration partner, GlaxoSmithKline. Anacor may receive future milestone payments ... Senior Vice President of Research at Anacor Pharmaceuticals. "We believe that our ...

Article: Anacor Raises $50 Million in Equity Financing.
PR Newswire;  January 6, 2009 ;     700+ words ... ... Calif., Jan. 6 /PRNewswire/ -- Anacor Pharmaceuticals today announced that it ... financing will be used to further develop Anacor's product pipeline based on its boron ... David Perry, Chief Executive Officer at Anacor Pharmaceuticals. The investments from ...

Article: Anacor Identifies a Novel Mechanism for Its Lead ...
PR Newswire;  June 21, 2007 ;     700+ words ... ... Article Also Demonstrates the Promise of Anacor's Boron-Based Chemistry in Developing ... Calif., June 21 /PRNewswire/ -- Anacor Pharmaceuticals, a privately held pharmaceutical ... Ph.D., head of discovery biology at Anacor and an author of the Science paper ...